Cidara Therapeutics(CDTX) - 2023 Q1 - Quarterly Report

Common Stock The Company had 200,000,000 shares of common stock authorized as of March 31, 2023. Holders of outstanding shares of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the holders of common stock. Subject to the rights of the holders of any class of the Company's capital stock having any preference or priority over common stock, the holders of common stock are entitled to receive dividends that are declared by the Company's board of directo ...